Hydroxyamine

Hydroxyamine

SCHEMBL4796191

NO.O=C(O)c1ccc2cc(Cc3ccc(F)cc3)[nH]c2c1

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 3/20 0.46
CASP3 P42574 1/20 0.45
SENP8 Q96LD8 1/20 0.45
SENP7 Q9BQF6 1/20 0.45
SENP6 Q9GZR1 1/20 0.45
F2 P00734 1/20 0.43
PIN1 Q13526 1/20 0.42
CHEK2 O96017 2/20 0.41
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
ENPP2 Q13822 1/20 0.40
HSD17B10 Q99714 1/20 0.40
ITK Q08881 2/20 0.39
APEX1 P27695 1/20 0.39
DAO P14920 2/20 0.38
DDO Q99489 1/20 0.38
BCL2L1 Q07817 1/20 0.38
BAD Q92934 1/20 0.38
TAS2R14 Q9NYV8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4803301 0.84 SRD5A2 (0.51) CASP3SENP8SENP7SENP6F2
Hydroxyamine SCHEMBL5618267 0.83 MRGPRX4 (0.46) CASP3SENP8SENP7SENP6CHEK2
SCHEMBL5132984 0.83 HDAC6 (0.51) PIN1ITK
Hydroxyamine SCHEMBL4807777 0.83 CASP3 (0.50) CASP3SENP8SENP7SENP6F2
SCHEMBL6950558 0.83 ITK (0.39) NR4A2CASP3SENP8SENP7SENP6
Hydroxyamine SCHEMBL5144256 0.82 KDM4A (0.50) CASP3SENP8SENP7SENP6F2
Hydroxyamine SCHEMBL4796509 0.81 LMNA (0.53) TAS2R14
SCHEMBL6990951 0.80 DAO (0.49) F2PIN1KDM4EDAODDO
Hydroxyamine SCHEMBL4795956 0.79 PDE5A (0.52) NR4A2CASP3SENP8SENP7SENP6
SCHEMBL7487224 0.77 MAP2K4 (0.47) PIN1DAODDO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008061160-A1 USES OF SELECTIVE INHIBITORS OF HDAC8 FOR TREATMENT OF INFLAMMATORY CONDITIONS PHARMACYCLICS, INC. (US) 2008-05-22 WO claimed